ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 64 • 2018 ACR/ARHP Annual Meeting

    Dietary Magnesium Modulates the Intestinal Microbiome and T Cell Subsets

    Teresina Laragione1, Carolyn Harris1 and Percio S. Gulko2, 1Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Several studies have demonstrated that Magnesium (Mg) has a key role in the immune responses. Our previous studies showed that a short-term low Mg…
  • Abstract Number: 65 • 2018 ACR/ARHP Annual Meeting

    Bacteria-Derived Indole Drives Autoimmune Arthritis By Altering B Cell Glycosylation of Autoantibodies

    Widian Jubair1, Erica Alexeev2, Timothy Lemke3, Meagan Chriswell1, Sean Colgan2 and Kristine A Kuhn1,2, 1Rheumatology, University of Colorado Denver, Aurora, CO, 2Mucosal Inflammation Program, University of Colorado Denver, Aurora, CO, 3University of Colorado Denver, Aurora, CO

    Background/Purpose: Ongoing studies in rheumatoid arthritis (RA) implicate intestinal dysbiosis of bacteria as a contributing factor, though the mechanism(s) by which bacteria influence disease is…
  • Abstract Number: 66 • 2018 ACR/ARHP Annual Meeting

    Suppression of Inflammatory Arthritis, in Human Paraoxonase 1 Transgenic Mice, Correlates with Upregulation of the Hepatic Glutathione Pathway and Reduction of Bioactive Lipid Mediators

    Christina Charles-Schoeman1, Ani Shahbazian2, Jennifer Wang3, Xiaoyan Wang2, Ernest Brahn2, Jeremy Papesh2, Victor Grijalva4 and Srinivasa T. Reddy2, 1Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 2University of California, Los Angeles, Los Angeles, CA, 3University of California Los Angeles, Los Angeles, CA, 4Medicine-Cardiology, University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Paraoxonase 1 (PON1) is an HDL-associated protein, which hydrolyzes biologically active oxidized phospholipids and prevents oxidation of lipids in LDL and HDL. Increased lipid…
  • Abstract Number: 67 • 2018 ACR/ARHP Annual Meeting

    Intestinal Inflammation and Netosis Associate with the Presence of Stool IgA ACPA in Subjects at-Risk for RA

    Widian Jubair1, Elizabeth A. Bemis2, Yuko Okamoto3, Marie L. Feser3, Jennifer Seifert3, M. Kristen Demoruelle3, Jill M. Norris4, Kevin D. Deane3, V. Michael Holers5 and Kristine A Kuhn1,6, 1Rheumatology, University of Colorado Denver, Aurora, CO, 2Epidemiology, Colorado School of Public Health, Aurora, CO, 3Division of Rheumatology, University of Colorado Denver, Aurora, CO, 4Department of Epidemiology, Colorado School of Public Health, Aurora, CO, 5Rheumatology Division, University of Colorado Denver, Aurora, CO, 6Mucosal Inflammation Program, University of Colorado Denver, Aurora, CO

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) and inflammation characterized by neutrophil extracellular trap (NET)osis have been detected at mucosal sites such as the lung and periodontium…
  • Abstract Number: 68 • 2018 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study Identifies rs116199914 As an Intergenic Variant Associated with Carotid Intima-Media Thickness in Spanish Patients with Rheumatoid Arthritis

    Raquel Lopez-Mejías1, Fernanda Genre1, Sara Remuzgo-Martínez1, David Carmona2,3, Verónica Pulito-Cueto1, Carlos González-Juanatey4, Alfonso Corrales1, Esther Vicente5, Jose A. Miranda-Filloy6, Beatriz-Segura Tejera7, Marco A. Ramírez Huaranga8, Verónica Mijares1, Leticia Lera-Gomez1, Ricardo Blanco1, Montserrat Robustillo-Villarino9, Javier Rodríguez-Carrio10, Ana Suárez10, Mercedes Alperi-López11, Francisco Javier Ballina-García12, Francisco Javier López Longo13, Francisco Javier Narváez14, Juan José Alegre9, Antonio Mera15, Eva Perez Pampín16, Antonio Gonzalez17, Enrique Raya Álvarez18, Chary López-Pedrera19, Carmen Gomez Vaquero14, Alejandro Balsa20, Dora Pascual-Salcedo20, Patricia Carreira21, Isidoro Gonzalez-Alvaro5, Luis Rodriguez Rodriguez22, Benjamin Fernandez Gutierrez22, Ivan Ferraz-Amaro23, Santos Castañeda24, Javier Martin3, Javier Llorca25 and Miguel Angel González-Gay1,26,27, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 2Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain, 3Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada, Granada, Spain, 4Division of Cardiology, Hospital Universitario Lucus Augusti, Lugo, Spain, 5Rheumatology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 6Rheumatology Department, Hospital Universitario Lucus Augusti, Lugo, Spain, 7Rheumatology Division, Hospital Insular de Gran Canaria, Las Palmas, Spain, 8Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, 9Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain, 10Area of Immunology, Department of Functional Biology, University of Oviedo, Oviedo, Spain, 11Department of Rheumatology, Hospital Universitario Central de Asturias, Asturias, Spain, 12Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo, Spain, 13Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 14Rheumatology Department, Hospital Universitario de Bellvitge, Idibell, Barcelona, Spain, 15Rheumatology Division. Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, 16Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, 17Laboratorio Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, 18Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 19IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 20Rheumatology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, 21Servicio de Reumatología, Hospital Universitario, Madrid, Spain, 22Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain, 23Rheumatology Division, Hospital Insular de Gran Canaria, La Laguna, Spain, 24Rheumatology, Rheumatology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 25School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 26School of Medicine, University of Cantabria, Santander, Spain, Santander, Spain, 27Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Cardiovascular (CV) disease is the most common cause of morbidity and mortality in patients with rheumatoid arthritis (RA) [1, 2]. Traditional CV risk factors…
  • Abstract Number: 69 • 2018 ACR/ARHP Annual Meeting

    Possible Association of Early Inflammatory Arthritis with Viral Outbreaks Such As Influenza: Time Series Analysis of the Canadian Early Inflammatory Arthritis Cohort

    Fatima Kudaeva1, Mark Speechley2, Neil Klar2, Orit Schieir3, Susan J. Bartlett4, Louis Bessette5, Gilles Boire6, Glen Hazlewood7, Carol A Hitchon8, Edward C. Keystone9, Diane Tin10, Carter Thorne11, Vivian P. Bykerk12 and Janet E. Pope13, 1Department of Epidemiology & Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, 2Epidemiology & Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, 3Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 4Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 5Division of Rheumatology, Department of Medicine, CHU de Québec-Université Laval, Québec, QC, Canada, 6Rheumatology Division, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 7Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, 8University of Manitoba, Winnipeg, MB, Canada, 9University of Toronto and Mount Sinai Hospital, Toronto, ON, Canada, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11University of Toronto, Newmarket, ON, Canada, 12Hospital for Special Surgery, New York, NY, 13Department of Medicine, University of Western Ontario, London, ON, Canada

      Background/Purpose: Disease clustering suggests a possible environmental cause. Rheumatoid arthritis (RA) is an autoimmune disease that may be triggered by environmental factors such as viruses.…
  • Abstract Number: 70 • 2018 ACR/ARHP Annual Meeting

    Colocalization of Malondialdehyde-Acetaldehyde Adducts (MAA) and Extracellular Matrix Proteins in Joint and Lung Tissues from Rheumatoid Arthritis Patients

    Geoffrey M. Thiele1, Michael J. Duryee2, Jacob D. McGowan1, Logan M. Duryee1, Lynell W. Klassen3, James R. O'Dell3, Bryant R. England4 and Ted R. Mikuls5, 1University of Nebraska Medical Center, Omaha, NE, 2Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 4Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, 5Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose:   Malondialdehyde-acetaldehyde adducts (MAA) are products of oxidative stress that modify self-proteins and stimulate potent cellular and humoral immune responses. We have previously demonstrated…
  • Abstract Number: 71 • 2018 ACR/ARHP Annual Meeting

    Association of Shared Epitope and Poor Prognostic Factors in RA

    Evo Alemao1, Joshua Bryson1, Christine K Iannaccone2, Michelle Frits2, Nancy A. Shadick3 and Michael Weinblatt2, 1Bristol-Myers Squibb, Princeton, NJ, 2Brigham and Women’s Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA

    Background/Purpose: There is a strong genetic association between RA and human leukocyte antigen (HLA) regions, particularly HLA-DRB1 alleles with the shared epitope (SE). SE alleles…
  • Abstract Number: 72 • 2018 ACR/ARHP Annual Meeting

    Altered Serologic Responses to Epstein Barr Virus Precede Clinical Disease Development in Rheumatoid Arthritis

    Heather M. Berens1, Elizabeth A. Bemis2, M. Kristen Demoruelle1, John B. Harley3, Judith A. James4, Jess Edison5, Kevin D. Deane1, Jill M. Norris6 and V. Michael Holers1, 1Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2Epidemiology, Colorado School of Public Health, Aurora, CO, 3Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Division of Rheumatology, Walter Reed National Military Medical Center, Bethesda, MD, 6Department of Epidemiology, Colorado School of Public Health, Aurora, CO

    Background/Purpose:    EBV infects B cells and is associated with several autoimmune diseases, including RA.  Prior studies have shown that patients with active classified RA…
  • Abstract Number: 73 • 2018 ACR/ARHP Annual Meeting

    Circular RNAs Expression Profile in Chinese Rheumatoid Arthritis Patients at Different Disease Activity

    Huan Liu, Qibing Xie and Geng Yin, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China

    Circular RNAs Expression Profile in Chinese Rheumatoid Arthritis Patients at Different Disease ActivityBackground/Purpose: Rheumatoid arthritis (RA) is an autoimmune-mediated chronic inflammatory joint disease, that is…
  • Abstract Number: 74 • 2018 ACR/ARHP Annual Meeting

    DNA Methylation of the Dual Specificity Protein Phosphatase 22 (DUSP22) Gene Promoter in Plasma of Patients with Seropositive and Seronegative RA

    Milena Rodriguez Alvarez1, Lissette Delgado-Cruzata2, Edgardo Guzman3, Wallis Tavarez3, Alorah Bliese2, Tagir Sabirov3, Maria-Jose Jimenez3, Carmen A Oviedo Hilario3, Manuel E. Acosta4, Maria Albarracin2, Carl Cirilli2, Zuleika Parra3, Cristabel Robles Hidalgo3, Christopher Mesa3, Dominyka Bitinaite3, Sabeeda Kadavath3, Ibrahim El Husseini3, Grace Thomas3, Augustas Kavaliauskas3, Kioumars Bolourian Kashi3, Michael Gebeyehu3, Dave Samip3, Pawan Suri3, Menachem Gold3 and Shante Hinson3, 1Rheumatology, SUNY Downstate, Brooklyn, NY, 2Sciences, John Jay College, City University of New York, New York, NY, 3Lincoln Medical and Mental Health Center, Bronx, NY, 4Barry University, Miami, FL

    Background/Purpose: The Dual specificity protein phosphatase 22 (DUSP22) gene is aberrantly methylated in mononuclear cells in RA, and it has been associated with erosive disease.…
  • Abstract Number: 75 • 2018 ACR/ARHP Annual Meeting

    Elevated Oxylipin Profile in Autoantibody-Positive Individuals at-Risk of Developing Rheumatoid Arthritis

    Vidyanand Anaparti1, Irene Smolik2, Tanja Winter3, Xiaobo Meng4, Harold Aukema3 and Hani El-Gabalawy4, 1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 2Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, 3Food and Nutritional Sciences, University of Manitoba, Winnipeg, MB, Canada, 4University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Preclinical phase of rheumatoid arthritis (RA) is characterized by presence of autoantibodies, including anti-citrullinated protein antibodies (ACPA), years before disease onset. Epidemiological observations suggest…
  • Abstract Number: 76 • 2018 ACR/ARHP Annual Meeting

    Whole Blood Targeted Bisulfite Pyrosequencing Identifies Differentially Methylated Regions within Major Histocompatibility Complex (MHC) of Patients with Rheumatoid Arthritis

    Vidyanand Anaparti1, Irene Smolik2, Prasoon Agarwal3, Neeloffer Mookherjee1 and Hani El-Gabalawy4, 1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 2Food and Nutritional Sciences, University of Manitoba, Winnipeg, MB, Canada, 3Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada, 4University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Human major histocompatibility complex (MHC) is strongly associated with rheumatoid arthritis (RA) pathogenesis. Epigenome-wide association study by Liu et al showed that differential DNA…
  • Abstract Number: 77 • 2018 ACR/ARHP Annual Meeting

    Single Nucleotide Polymorphism in the Gene Encoding Peptidylarginine Deiminase 4 Correlates with Reduced Neutrophil Extracellular Traps and Anti-Histone Antibodies in Rheumatoid Arthritis

    Aisha M. Mergaert1, Mandar Bawadekar2, Thai Q. Nguyen1, Steven J. Schrodi3,4 and Miriam A. Shelef2,5, 1University of Wisconsin - Madison, Madison, WI, 2Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, Madison, WI, 3Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 4Computation and Informatics in Biology and Medicine, University of Wisconsin - Madison, Madison, WI, 5William S. Middleton Memorial Veterans Hospital, Madison, WI

    Background/Purpose: In neutrophils, peptidylarginine deiminase 4 (PAD4) citrullinates histones allowing chromatin unraveling and neutrophil extracellular trap (NET) formation. NETs are increased and display proteins targeted…
  • Abstract Number: 78 • 2018 ACR/ARHP Annual Meeting

    Decreased B Cell Ataxia-Telangiectasia Mutated Expression and Receptor Diversity Identify a Subset of Rheumatoid Arthritis Patients with Increased Joint Erosion Prevalence

    Kofi Mensah1, Jean-Nicolas Schickel2, Isabel Isnardi2 and Eric Meffre2, 1Section of Rheumatology, Yale University School of Medicine, New Haven, CT, 2Department of Immunobiology, Yale University School of Medicine, New Haven, CT

    Background/Purpose: A skewed B cell receptor (BCR) repertoire was observed in some RA patients. In these patients, BCR κ light chains contain a higher percentage…
  • « Previous Page
  • 1
  • …
  • 1007
  • 1008
  • 1009
  • 1010
  • 1011
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology